Graphene-Based Biomaterials for Bone Tissue Engineering: A Scoping Review Dataset

77 studies published between 2010 and 2022 were selected for a scoping review on graphene's use in preclinical bone tissue regeneration. The dataset includes manuscript abstracts and an EndNote library, compiled by researcher Gustavo Achoa following PRISMA-ScR guidelines. Boolean searches on PubMed/MEDLINE, Embase, Web of Science, Cochrane Central, and clinicaltrials.gov identified studies using graphene, graphene oxide, and reduced graphene.

Use Cases

• Systematic review and meta-analysis based on the collection of 77 selected studies.
• Bibliometric analysis of graphene research trends in bone tissue engineering from 2010 to 2022.
• Identifying composite material strategies based on mentions of graphene combined with natural/synthetic polymers and bioglass.
• Evaluating preclinical outcomes such as osteoconductivity and angiogenesis based on the review's synthesized conclusions.

Strengths

• Follows a structured scoping review methodology based on Joanna Briggs Institute and PRISMA-ScR guidelines.
• Includes 77 studies selected after a defined search protocol and application of inclusion criteria.
• Searches were conducted across five major databases (PubMed/MEDLINE, Embase, Web of Science, Cochrane Central, clinicaltrials.gov).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the abstract/library data is unknown, which may limit suitability assessment.
• Last update date is unknown; freshness unverified.

Provenance

Source

paperswithcode

Collection Method

Boolean searches using keywords 'bone' and 'graphene' across multiple databases; abstracts uploaded to Rayyan for review.

Time Range

2010 to 2022